RNA Processing and Intro to Translation

Announcements

  • Exam 2 is next week, Wednesday through Friday (Mar. 12-14).

    • Ensure timely CBTF reservation.

  • Friday, March 14 is the drop deadline.

  • Lectures:

    • Monday: Concludes Exam 2 material.

    • Wednesday (March 12): Exam 3 material.

    • Friday the 14th: No class.

  • Practice Exam 2: Available with a board for questions.

  • Student hours:

    • Today 4:00-5:30 in 124 Burrill Hall.

    • Friday 9:30-11:00 via Zoom.

Intron Removal and Exon Splicing (Eukaryotic mRNA Processing)

  • Introns exhibit significant length variation (tens to tens of thousands of bases).

  • Occurs post-transcriptionally but usually concurrently with transcription.

  • Completion is mandatory before mRNA export from the nucleus.

  • Splice point conservation: Sequences at intron ends are conserved, marking splice points. The remaining intron sequence may have regulatory functions.

  • Mechanism: Carried out by snRNPs (small nuclear RNA molecules and proteins). These precisely remove introns and join exon ends.

Inaccurate Splicing

  • Consequences: Leads to non-functional proteins.

  • Thalassemias: Often results from inaccurate intron splicing affecting hemoglobin production.

  • Mutations:

    • DNA mutations are carried over to RNA.

    • Disrupt snRNP recognition of intron/exon junctions.

    • Intron retention occurs.

  • False splice sites: snRNPs may utilize incorrect splice sites, leading to the removal of necessary exon sequences and defective protein synthesis.

Genome Size and Complexity

  • Human genome: Contains approximately 21,000 genes, which is less than initially hypothesized.

  • Gene count: Not substantially more than simpler organisms like fruit flies and nematode worms.

  • Gene size consistency: Coding region size is generally similar across different organisms.

  • Gene assembly: Human genes utilize extensive combinatorial arrangements of coding regions through alternative splicing.

Alternative Splicing

  • Exon usage: Not all exons in primary mRNA are necessarily included in the final transcript.

  • Outcome: Different mature mRNAs are produced, leading to different proteins.

  • Prevalence: Affects 50% to 90% of human genes.

    • Transcript variability: A gene can produce from 2 to thousands of different transcripts.

    • Human average: Approximately 3-4 different transcripts per gene.

  • Protein diversity: Accounts for the production of around 100,000 proteins from 21,000 genes via different combinations of exons.

Additional Processing of Eukaryotic mRNAs (5′ end)

  • RNA 5’-triphosphatase: Removes a phosphate Pi\text{P}_i.

  • Guanylyl transferase: Hydrolyzes GTP, attaching GMP to the 5’ end and releasing PPi\text{PP}_i.

  • Methyltransferase: Attaches a methyl group to the 5’ end.

Additional Eukaryotic mRNA Processing (3′ end)

  • Poly(A) tail: Added post-transcriptionally to the 3′ end by poly-A polymerase to enhance stability and translation efficiency.

Function of 5′ Cap

  • Start signal: Facilitates recognition of the mRNA as the starting point for translation.

  • Stability: Offers protection against degradation by RNases, thereby enhancing mRNA stability.

Function of Poly-A Tail

  • Stability: Provides temporary stability by protecting against RNase degradation.

  • Translation efficiency: Aids in efficient protein production from a single mRNA molecule.

Summary of mRNA Processing in Eukaryotes

  • Includes:

    • Capping at 5' end.

    • Poly-A addition at 3' end.

    • Excision and splicing.

Location of mRNA Processing

  • Bacteria: Location not specified in transcript.

  • Eukaryotes: Location not specified in transcript.

Translation

  • Protein synthesis: mRNA converted into protein.

  • Genetic information: Nucleotide sequence (ACGU) contains protein synthesis instructions.

    • Building blocks: Proteins are composed of amino acids.

  • Codon-amino acid relationship: No direct one-to-one relationship between a single nucleotide and an amino acid.

Codon Size

extensive

  • Limitations of one-to-one coding: If each nucleotide coded for one amino acid, only 4 amino acids could be specified, insufficient for the 20 required.

  • Two-nucleotide combinations:

    • Possibilities: 42=164^2 = 16 combinations.

    • Insufficiency: Still not adequate to code for 20 amino acids.

  • Three-nucleotide combinations:

    • Calculation: 4×4×4=43=644 \times 4 \times 4 = 4^3 = 64

    • Adequacy: Minimum number of nucleotides required to code for all 20 amino acids.

Deciphering the Genetic Code

  • Artificial mRNA synthesis: Created a synthetic mRNA with 60 Uracils—5′-UUUUUUUUUUU…UUUU-3′ (poly-U).

  • In vitro translation: Fed the synthetic mRNA to a protein synthesis system.

    • Result: Produced a polypeptide of 20 Phenylalanines, confirming that UUU codes for Phenylalanine and the code is triplet.

  • Further experiments:

    • Revealed the specification of each of the 64 codons.

    • 61 codons specify amino acids.

    • 3 codons indicate the end of protein synthesis (stop codons).

  • Redundancy in the genetic code:

    • Degeneracy: Most amino acids are coded by multiple codons.

    • Unambiguous: Each codon specifies only one amino acid.

    • Non-overlapping: Codons are read sequentially without overlap.